US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE NANTES, OSE IMMUNOTHERAPEUTICS on Oct. 21 for "Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof" (French Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,454, issued on Oct. 21, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), UNIVERSITE DE NANTES (Nantes, France) and OSE IMMUNOTHERAPEUTICS (Nantes, France).

"Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof" was invented by Sabrina Pengam (St Luce S/ Loire, France), Vanessa Gauttier (Reze, France), Caroline Mary (Sainte-Pazanne, France), Nicolas Poirier (Grandchamps des Fontaines, France), Marion Drouin (Savenay, France) and Elise Chiffoleau (Nantes, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention pertains to the field of immunotherapy. The present invention provide...